Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction in aging men: testosterone role in therapeutic protocols.

N Caretta1, A Ferlin, P F Palego

  • 1Department of Histology, Microbiology and Medical Biotechnologies, Centre for Male Gamete Cryopreservation, University of Padua, 35128 Padua, Italy.

Journal of Endocrinological Investigation
|June 9, 2006
PubMed
Summary

Low testosterone levels (hypogonadism) are common in older men with erectile dysfunction (ED). Testosterone therapy may improve erectile function, especially when combined with PDE5 inhibitors for men unresponsive to these drugs alone.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current drawbacks and future perspectives in the diagnosis and treatment of male factor infertility, with a focus on FSH treatment: an expert opinion.

Journal of endocrinological investigation·2025
Same author

Additive effect of Bisphenol A and Pefluoro-sulphoctanoic acid exposure at subacute toxic levels, on a murine model of sertoli cell.

Journal of endocrinological investigation·2024
Same author

Communication of the diagnosis to Klinefelter subjects: an observational study on a key moment of the patient's life.

Journal of endocrinological investigation·2024
Same author

HPV-related diseases in male patients: an underestimated conundrum.

Journal of endocrinological investigation·2023
Same author

Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.

Journal of endocrinological investigation·2023
Same author

The Italian Society of Andrology and Sexual Medicine (SIAMS), along with ten other Italian Scientific Societies, guidelines on the diagnosis and management of erectile dysfunction.

Journal of endocrinological investigation·2023

Area of Science:

  • Andrology
  • Urology
  • Endocrinology

Background:

  • Aging in men is linked to decreased libido and sexual activity.
  • Biochemical hypogonadism (low testosterone) affects a significant proportion of men over 60.
  • Hypoandrogenism may contribute to erectile dysfunction (ED) and reduced response to PDE5 inhibitors.

Purpose of the Study:

  • To investigate the role of testosterone in aging men with ED.
  • To evaluate the efficacy of testosterone treatment in hypogonadal men with ED.
  • To determine if testosterone therapy improves response to PDE5 inhibitors.

Main Methods:

  • Assessed erectile function in hypogonadal men before and after testosterone treatment.
  • Evaluated response to sildenafil and apomorphine in hypogonadal men.

Related Experiment Videos

  • Measured nitric oxide (NO) production and endothelial progenitor cell (EPC) numbers.

    • Main Results:

    • Testosterone treatment stimulated nitric oxide (NO) production and improved endothelial repair via increased endothelial progenitor cells (EPCs).
    • Hypogonadal men treated with testosterone showed normal erectile responses to apomorphine and sildenafil.
    • Testosterone therapy positively influenced central and peripheral erection control, endothelial function, and PDE5 expression.

    Conclusions:

    • Plasma testosterone levels should be measured in aged men with ED.
    • Testosterone replacement therapy is recommended for hypogonadal men with ED, barring contraindications.
    • Combining testosterone with PDE5 inhibitors may benefit hypogonadal men with ED unresponsive to PDE5 inhibitors alone.